Satellos Bioscience Inc.

TSX:MSCL.TO

Biotechnology

Healthcare
$8.62 +0.12%

+$0.01 today

Market cap
$182.89M
Beta
1.17
P/E (TTM)
-1.8
EPS (TTM)
-$0.32
52W Low $6.36High $18.98

Volume 0.01M

Average 0.02M

Returns on capital

Satellos Bioscience Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-91.3%

avg -21.5%

ROIC

-97.1%

avg -101.1%

ROA

-79.5%

avg -176.1%

Analysis

ROA is currently the strongest return metric at -79.5% versus its period average of -176.1%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Francis Gleeson

Co-Founder, Chief Executive Officer, President & DirectorCAD 922.14K71——

Philip Lambert

Chief Scientific OfficerCAD 805.11K57——

Elizabeth Williams

Chief Financial Officer & Corporate SecretaryCAD 681.36K48——

Wildon Farwell

Chief Medical OfficerCAD 406.69K50——

Warren Whitehead

Head of Corporate StrategyCAD 313.54K74——

Michael A. Rudnicki

Co-Founder & Chief Discovery OfficerCAD 120K64——

Michael Liggett

Strategic AdvisorCAD 44.48K66——

Ryan Mitchell

Senior VP & Head of Corporate Development————

J. Robert Hall

Senior Vice President of Finance & Administration————

Antoinette Paone

Chief Development Officer & Head of Regulatory Affairs—47——

Desiree Chan

Chief of Staff————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

No open-market purchases or sales in the last 12 months.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/AN/A
N/A0 analysts
Net IncomeN/AN/AN/A
N/A0 analysts
EBITN/AN/AN/A
N/A0 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Competitors

Who does Satellos Bioscience Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about MSCL.TO's management, answered from reported figures.

Who manages MSCL.TO?

Satellos Bioscience Inc. (MSCL.TO) lists 11 active executives. The top listed executive is Michael A. Rudnicki, Co-Founder & Chief Discovery Officer.